Spatial biology organisations develop technologies and services that analyse cells, genes and proteins while preserving their location within tissues. These approaches help researchers understand tissue organisation, cellular interactions and disease biology while retaining spatial context.
This category includes companies working on:
Browse 24 UK spatial biology companies, service providers and research organisations below.
Human tissue research CRO supporting preclinical drug discovery
Pharmagene Discovery Services is a UK contract research organisation specialising in laboratory-based research services using consented human tissue and primary human cells. The company provides tailored assay design and development across target expression, spatial biology, functional cellular biology, bioassays, and…
Open biological data resources and bioinformatics services for life sciences
EMBL-EBI is the European Bioinformatics Institute, an intergovernmental research organisation and part of the European Molecular Biology Laboratory (EMBL). Located on the Wellcome Genome Campus in Hinxton, it maintains a suite of freely available molecular biology databases including UniProt, Ensembl, Expression Atlas…
Antibody-oligonucleotide conjugates for spatial biology and proteomics
AbOliGo is a biotechnology company developing antibody-oligonucleotide conjugates (AOCs) for multiplexed protein analysis, spatial biology and single-cell workflows. Its conjugation platform addresses a critical bottleneck in multiomic research, as fewer than 0.1% of commercially available antibodies are currently…
University research institute advancing stem cell biology and therapeutics
Cambridge Stem Cell Institute is a University of Cambridge research institute investigating stem cell biology, tissue maintenance and disease. Its research groups study stem cell states, disease mechanisms and therapeutic applications using cell culture, genomics, imaging and experimental models. Based at Cambridge…
Multiplexed imaging platform for therapeutic mechanism of action discovery
Micrographia Bio is a biotechnology company developing a spatial proteomics platform for drug discovery. Its technology combines highly multiplexed microscopy with machine-intelligent computer vision to autonomously determine the mechanism of action of therapeutic candidates by visualising protein-protein interactions…
NHS-embedded specialist pathology services and clinical biobank access
Novopath is the commercial pathology laboratory of Newcastle upon Tyne Hospitals NHS Foundation Trust, providing specialist tissue-based diagnostic and research services to biopharma, biotech, and academic clients. Services include histopathology, immunohistochemistry, tissue microarray construction, digital…
University genomics core facility for sequencing, single-cell and spatial analysis
The Imperial BRC Genomics Facility is a university core facility supporting translational genomics research. It provides next-generation sequencing, single-cell genomics, spatial transcriptomics and proteomics, alongside experimental design, library preparation and bioinformatics analysis. Its services are used to…
Cambridge cancer research institute advancing discovery and clinical translation
Cancer Research UK Cambridge Institute is a cancer research institute within the University of Cambridge, investigating tumour biology, early detection and treatment. Its research groups study cancer evolution, genomics and the tumour microenvironment, using imaging and computational approaches to improve diagnosis…
UK distributor of analytical instruments for life science laboratories
Verulam Scientific is a specialist distributor of analytical instruments and laboratory systems serving the UK pharmaceutical, clinical, life science, environmental, and biotechnology markets. The company represents a portfolio of European and US manufacturers, supplying and supporting systems in HPLC electrochemical…
Quantitative digital pathology image analysis services for pharma
OracleBio is a contract research organisation specialising in quantitative digital pathology and histopathology image analysis. The company delivers high-precision tissue biomarker quantification services to pharmaceutical and biotechnology clients, supporting pre-clinical and clinical research programmes. Services…
Single-cell genomics and AI platform for autoimmune and fibrotic disease
Ensocell is a Cambridge-based biotechnology company developing precision biologics for autoimmune, inflammatory, and fibrotic diseases. Its platform integrates single-cell and spatial genomics with AI-based computational tools and advanced cell models to identify novel disease intervention points and design targeted…
RNA immunotherapies targeting novel tumour-specific antigens
Epitopea is a biopharma company developing off-the-shelf RNA-based immunotherapies for hard-to-treat cancers. Using spatial immunopeptidomics, genomics, and systems bioinformatics, the company identifies aberrantly-expressed tumour-specific antigens that are broadly shared across patients with the same tumour type.…
Mechanobiology platform for target discovery and validation
Mechanome Bio is a Cambridge-based company developing a mechano-transcriptomics platform for biomarker and drug target discovery. The platform combines spatial multi-omics data from human tissue samples with mechanical tissue profiling and in silico tissue modelling to identify targets linked to changes in tissue…
Precision therapeutics targeting fibrosis using multi-omics
Forth Therapeutics develops precision medicines intended to target the cellular mechanisms driving organ fibrosis. Its discovery platform combines single-cell and spatial genomics with patient-derived tissue data, including a large human liver disease dataset. These insights help identify disease-associated cells and…
Intestinal barrier repair therapies for inflammatory bowel disease
Thelior Bio is a University of Oxford spin-out developing therapies for inflammatory bowel disease, including Crohn's disease and ulcerative colitis. Its research focuses on restoring the intestinal epithelial barrier, addressing impaired tissue repair associated with chronic inflammation. The company draws on…
Large-scale genomics research institute advancing human and pathogen biology
The Wellcome Sanger Institute is a genomics research institute on the Wellcome Genome Campus in Hinxton, funded by Wellcome. It made the largest single contribution to the Human Genome Project and has since expanded across cancer genomics, cellular genetics, infectious disease and parasitology. Research programmes…
AI platform for bone marrow morphology analysis
Ground Truth Labs is an Oxford-based computational pathology company applying machine learning and computer vision to decode disease in bone marrow tissue. Its platform quantifies morphological markers including fibrosis, blasts, and plasma cells at slide and cell level, and identifies novel prognostic patterns…
University spatial transcriptomics and imaging platform for tissue research
The DRP Spatial Platform is a university core facility that supports spatial transcriptomics and imaging projects. It offers experimental design, histology and sample preparation, tissue imaging and laser capture microdissection, and spatial gene expression profiling, with support for data quality control and…
AI-powered multi-omic data analytics for precision medicine
Sonraí Analytics is a software company providing cloud-based AI and bioinformatics analytics for pharmaceutical, biotechnology and clinical research organisations. The platform integrates multi-omic, imaging, and clinical data within a secure research environment to support drug target identification, biomarker…
Specialist molecular pathology, histopathology and spatial biology CRO
Propath (UK) is a contract research organisation providing GLP and GCP-compliant molecular pathology, histopathology, and spatial biology services to the global biopharmaceutical industry. Operating from a dedicated 12,000 square foot facility in Hereford, the company delivers spatial transcriptomics, highly…